Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Online Prenatal Trial in Mindfulness Sleep Management (OPTIMISM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04016428
Recruitment Status : Not yet recruiting
First Posted : July 11, 2019
Last Update Posted : July 11, 2019
Sponsor:
Collaborator:
National Institute of Nursing Research (NINR)
Information provided by (Responsible Party):
Ira Kantrowitz-Gordon, University of Washington

Brief Summary:
The aim of this study is to assess an online mindfulness intervention for pregnant women (6 weeks) for the treatment of insomnia and prevention of depression relapse in pregnancy. This mindfulness intervention will also be compared with an online intervention (6 weeks) consisting only of education about insomnia in pregnancy. The principal hypothesis is that the mindfulness intervention will be more effective than the education-only intervention.

Condition or disease Intervention/treatment Phase
Pregnancy Related Insomnia Depression Behavioral: OPTIMISM Behavioral: Sleep Education Not Applicable

Detailed Description:

The aim of this study is to assess an online mindfulness intervention for pregnant women (6 weeks) for the treatment of insomnia and prevention of depression relapse in pregnancy.

There will be two groups:

  1. An online mindfulness intervention for pregnant women (6 weeks) that focuses on behaviors to overcome sleep difficulties in pregnancy.
  2. An online control group that will receive information about sleep in pregnancy (6 weeks).

Each group will be composed of 25 participants with a total sample of 50. The principal hypothesis is that the mindfulness intervention will be more effective than sleep education in the improvement of sleep and depression symptoms during pregnancy.

The differences between the intervention and control group will be analyzed. The acceptability and usability of online content will also be assessed.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Online Prenatal Trial in Mindfulness Sleep Management
Estimated Study Start Date : July 2019
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : May 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: OPTIMISM Intervention
Participants will receive online delivery of a mindfulness-based program for improving sleep in pregnancy, along with the usual care they would receive from their provider.
Behavioral: OPTIMISM
Six-week online program that emphasizes mindfulness and skills for improving sleep during pregnancy.

Active Comparator: Sleep Education
Participants will receive online delivery of an education program on sleep in pregnancy, along with the usual care they would receive from their provider.
Behavioral: Sleep Education
Six-week online program that provides education on sleep during pregnancy.




Primary Outcome Measures :
  1. Pittsburgh Sleep Quality Index (PSQI) [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    Self-rating of overall sleep quality and disturbances using 7 sleep components. Total scores range from 0 to 21, with higher scores indicating worse sleep quality. PSQI global >5 is highly sensitive and specific for distinguishing good and poor sleepers. A lower PSQI score is a better outcome.


Secondary Outcome Measures :
  1. Sleep efficiency [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    Sleep efficiency will be calculated from total sleep time divided by time in bed, as measured by 8 days of wrist actigraphy and sleep diaries. Increased sleep efficiency is a better outcome.

  2. Total wake time [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    Total wake time will include all time spent in bed awake, measured in minutes. This will be measured by actigraphy and sleep diaries, and will be calculated as the sum of sleep onset latency (time from getting into bed to falling asleep) and wake after sleep onset (time awake after sleep onset). Decreased total wake time is a better outcome.

  3. Total sleep time [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    Total sleep time is the sum of all time spent asleep, measured in minutes. This will be measured by actigraphy and sleep diaries, and calculated as the difference between time in bed and total wake time. Increased total sleep time is a better outcome.

  4. Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A six-item self-report questionnaire that measures perception of the quality of sleep over the past seven days. Total score ranges from 6 to 30, with higher scores indicating more disturbed sleep. Decreased sleep disturbance is a better outcome.

  5. PROMIS Sleep-Related Impairment Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    An eight-item self-report questionnaire for perceptions of alertness, sleepiness, and tiredness during usual waking hours, and the perceived functional impairments during wakefulness associated with sleep problems or impaired alertness. Total scores range from 8 to 40, with higher scores indicating increased impairment over the past 7 days. Decreased impairment is a better outcome.

  6. PROMIS Fatigue Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A six-item self-report questionnaire for reporting subjective feelings of tiredness and the impact on the ability to function normally over the past seven days. Total scores range from 6 to 30, with higher scores indicating increased fatigue. Decreased fatigue is a better outcome.

  7. Edinburgh Postnatal Depression Scale (EPDS) [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A ten-item self-report questionnaire for depression symptoms in the past week validated for use during pregnancy and postpartum. Total scores range from 0 to 30, with higher scores indicating increased symptoms of depression. Decreased depression is a better outcome.

  8. PROMIS Depression Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A six-item self-report questionnaire for depression symptoms in the past week. Total scores range from 6 to 30, with higher scores indicating increased symptoms of depression. Decreased depression is a better outcome.

  9. PROMIS Anxiety Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A six-item self-report questionnaire for anxiety symptoms in the past week. Total scores range from 6 to 30, with higher scores indicating increased symptoms of anxiety. Decreased anxiety is a better outcome.

  10. Neuro-QOL Positive Affect and Well-Being Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A nine-item self-report questionnaire for recent frequency of positive emotions. Total scores range from 9 to 45, with higher scores indicating increased positive emotions. A higher score is a better outcome.

  11. Short Form (36) Health Survey [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A 36-item, patient-reported survey of patient health status and quality of life. Total scores range from 0 to 100, with lower scores indicating increased disability. Increased scores are a better outcome.

  12. Intervention adherence [ Time Frame: Intervention completion (6 weeks) ]
    Intervention adherence will be measured as the number of intervention modules completed, with a range of 0 to 6. Increased modules completed indicates greater intervention adherence and is a better outcome.

  13. Meditation adherence [ Time Frame: Intervention completion (6 weeks) ]
    Meditation adherence will be measured by the average number of days per week the participant practiced at least one meditation, with a range of 0 to 7. Increased meditation adherence is a better outcome.

  14. Intervention acceptability [ Time Frame: Intervention completion (6 weeks) ]
    Acceptability will be measured by a self-report 8-item questionnaire on program satisfaction, utility, and ease of use. The range of total scores is 8 to 40, with higher scores indicating increased acceptability. Higher acceptability is a better outcome.


Other Outcome Measures:
  1. PROMIS Self-Efficacy for Managing Emotions -- Short Form [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A four-item self-report questionnaire for measuring confidence in handling emotions. Total scores range from 4 to 20, with higher scores indicated greater ability to handle emotions. Increased confidence is a better outcome.

  2. Index of Self-Regulation (ISR) [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A nine-item self-report questionnaire designed to measure individuals' level of motivation and self-regulation for health-related behavior change. Total scores range from 6 to 54, with higher scores indicating greater self-regulation. Increased self-regulation is a better outcome.

  3. Sleep Problem Acceptance Questionnaire (SPAQ) [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    An 8-item self-report questionnaire that assesses acceptance of insomnia. Total scores range from 0 to 48, with higher scores indicating a higher level of acceptance. Increased acceptance is a better outcome.

  4. Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF) [ Time Frame: Enrollment to intervention completion (6 weeks) ]
    A 24-item self-report questionnaire that measures the trait-like tendency to be mindful in daily life. It includes five subscales, measuring different aspects of mindfulness. Four of the subscale scores range from 5 to 25; one subscale ("observing") has a range of 4 to 20. Higher scores indicate increased mindfulness, which is a better outcome.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

1) Viable pregnancy in second trimester (up to 28 weeks gestation); 2) prior diagnosis of depression currently in remission (score < 3 on the Patient Health Questionnaire (PHQ-2) depression screening questionnaire); 3) subjective report of insomnia (score > 7 on the Insomnia Severity Index); 4) age 18 or older; 5) access to an Internet-enabled smartphone, tablet, or computer; and 6) English fluency. Participants will not be excluded from participation if they are currently receiving psychotropic medications or psychotherapy.

Exclusion Criteria:

1) Known severe congenital fetal anomalies, fetal demise, or expected neonatal death; 2) diagnosis of major depressive disorder within past 2 months; 3) other significant psychiatric illness requiring treatment; 4) current hospitalization; 5) prior diagnosis of obstructive sleep apnea or restless leg syndrome; 6) positive self-report screen for restless leg syndrome; 7) regular mindfulness or meditative practice (at least weekly); and 8) regular night-shift work.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04016428


Contacts
Layout table for location contacts
Contact: Ira Kantrowitz-Gordon, PhD, CNM (206) 543-8231 irakg@uw.edu

Locations
Layout table for location information
United States, Washington
University of Washington Not yet recruiting
Seattle, Washington, United States, 98195
Contact: Ira Kantrowitz-Gordon, PhD, CNM         
Sponsors and Collaborators
University of Washington
National Institute of Nursing Research (NINR)
Investigators
Layout table for investigator information
Principal Investigator: Ira Kantrowitz-Gordon, PhD, CNM University of Washington

Layout table for additonal information
Responsible Party: Ira Kantrowitz-Gordon, Assistant Professor, University of Washington
ClinicalTrials.gov Identifier: NCT04016428     History of Changes
Other Study ID Numbers: STUDY00005267
5P30NR016585-02 ( U.S. NIH Grant/Contract )
First Posted: July 11, 2019    Key Record Dates
Last Update Posted: July 11, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Data will be shared via the Common Data Repository for Nursing Science (cdRNS) at the National Institute of Nursing Research.
Supporting Materials: Study Protocol
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Time Frame: Data will become available 6 months after study start-up and will continue to be available throughout the study.
Access Criteria: Steps to access data are available at https://cdrns.nih.gov/access-data

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ira Kantrowitz-Gordon, University of Washington:
sleep
pregnancy
insomnia
depression
mindfulness

Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Sleep Initiation and Maintenance Disorders
Behavioral Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Mental Disorders